BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.56 +0.36 (+16.36%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Oncology Therapeutics (BBOT) Receivables - Net (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics' Receivables - Net was $661,000 in Q2 2026, up 352.7% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Receivables - Net (2024 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Net at BridgeBio Oncology Therapeutics came in at $386,000, up 376.5% from FY2024.

  • In earlier years, Receivables - Net was $81,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BridgeBio Oncology Therapeutics 176.55 Mn -920.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 155,000.00
Jun 30, 2026 661,000.00
Mar 31, 2026 146,000.00
Dec 31, 2025 386,000.00
Sep 30, 2025 226,000.00
Dec 31, 2024 81,000.00
API Access

BridgeBio Oncology Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=BBOT&period=max&api_key=YOUR_API_KEY